Caught on Cam: Novo Nordisk Executive Collapses in Oval Office
Gordon Findlay, an executive at Novo Nordisk, collapsed in the Oval Office on Thursday afternoon during President Trump’s announcement of a plan to reduce the price of weight-loss drugs, including Ozempic.
He was quickly assisted to his feet and received medical attention. Officials expect him to recover fully.
"Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
Event Details
- Incident occurred during a public announcement by President Trump regarding affordability of weight-loss medications.
- Immediate medical aid was provided to Gordon Findlay.
- No further complications have been reported.
Related Topics
- Weight-loss drug pricing reforms
- Ozempic and its market impact
- Health policy updates under President Trump
"President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic."
Additional Information
This incident was captured on camera and has drawn attention to both the health policies being discussed and the unexpected medical event at the announcement.
Author’s summary: During a significant policy announcement by President Trump on weight-loss drug pricing, Novo Nordisk executive Gordon Findlay collapsed but is expected to recover after prompt medical assistance.